男人女人午夜视频免费,免费人妻无码不卡中文字幕系,国产A级三级三级三级,成年无码aⅴ片在线观看

衰老關(guān)鍵蛋白1(FBLN1)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法)

ELISA Kit DIY Materials for Fibulin 1 (FBLN1)

  • 衰老關(guān)鍵蛋白1(FBLN1)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法)產(chǎn)品包裝(模擬)
  • 衰老關(guān)鍵蛋白1(FBLN1)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法)產(chǎn)品包裝(模擬)
  • Certificate通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

試劑盒中的抗體對衰老關(guān)鍵蛋白1(FBLN1)具有高靈敏度和高特異性，經(jīng)檢測與其它相似物質(zhì)無明顯交叉反應(yīng)。

用法

1.用100μL每孔的工作濃度的包被抗體包被96孔板，4度孵育過夜或者37度孵育2小時；
2.洗板1次；
3.用200μL每孔的工作濃度的封閉液,37度孵育1.5小時；
4.洗板1次。酶標(biāo)板即可用于ELISA實驗，后續(xù)使用方法與ELISA同。

儲存

抗體，標(biāo)準(zhǔn)品和HRP標(biāo)記的鏈霉親和素在-20度保存，TMB需在4度保存，96孔板在室溫保存。所有組分保質(zhì)期為1年，試劑一旦開封，在4度保存時間為1個月。

配套試劑

相關(guān)產(chǎn)品

編號適用物種：Homo sapiens (Human，人)應(yīng)用(僅供研究使用，不用于臨床診斷！)
RPC472Hu02衰老關(guān)鍵蛋白1(FBLN1)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPC472Hu03衰老關(guān)鍵蛋白1(FBLN1)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPC472Hu01衰老關(guān)鍵蛋白1(FBLN1)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAC472Hu02衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體WB
PAC472Hu01衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體WB
PAC472Hu03衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體WB
FAC472Hu01抗衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體FCM
FAC472Hu03抗衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體Flow cytometry.
LAC472Hu71衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體(生物素標(biāo)記)WB; IHC; ICC.
MAC472Hu21衰老關(guān)鍵蛋白1(FBLN1)單克隆抗體WB; IHC
MAC472Hu22衰老關(guān)鍵蛋白1(FBLN1)單克隆抗體WB; IHC
FAC472Hu02抗衰老關(guān)鍵蛋白1(FBLN1)單克隆抗體FCM
LAC472Hu72衰老關(guān)鍵蛋白1(FBLN1)單克隆抗體(生物素標(biāo)記)WB; IHC; ICC.
SEC472Hu衰老關(guān)鍵蛋白1(FBLN1)檢測試劑盒(酶聯(lián)免疫吸附試驗法)Enzyme-linked immunosorbent assay for Antigen Detection.
SCC472Hu衰老關(guān)鍵蛋白1(FBLN1)檢測試劑盒(化學(xué)發(fā)光免疫分析法)Chemiluminescent immunoassay for Antigen Detection.
LMC472Hu衰老關(guān)鍵蛋白1(FBLN1)等多因子檢測試劑盒(流式熒光發(fā)光法)FLIA Kit for Antigen Detection.
PSC472Hu01衰老關(guān)鍵蛋白1(FBLN1)抗體對ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
KSC472Hu01衰老關(guān)鍵蛋白1(FBLN1)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法)Main materials for "Do It (ELISA Kit) Yourself".

參考文獻(xiàn)

雜志參考文獻(xiàn)
Clin Exp Metastasis.Augmented expression of urokinase plasminogen activator and extracellular matrix proteins associates with multiple myeloma progression[Pubmed:24807734]
Proteomics Clinical ApplicationsComparative mass spectrometric and immunoassay‐based proteome analysis in serum of Duchenne muscular dystrophy patients[Pubmed:26680509]
PROTEOMICS?-?Clinical?ApplicationsComparative mass spectrometric and immunoassay-based?proteome?analysis?in?serum?ofDuchenne muscular dystrophy?patients.[pubmed:26680509]
ENVIRONMENTAL RESEARCHExploration of identifying novel serum biomarkers for malignant mesothelioma using iTRAQ combined with 2D-LC-MS/MS[Pubmed: 33197421]